Delivery Order SPE2DB24D2205-SPE2DB25FEDCJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on April 22, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by May 13, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $15,151.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 70 mg capsules (28-count units) on October 16, 2025, with an ultimate completion date of November 6, 2025. This non-set-aside competitive award is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 70 mg capsules (28-count packaging) under a firm fixed price contract type. This delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is classified...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on August 18, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp for IMBRUVICA 70 mg capsules (28-count) on August 28, 2025, with a completion date of September 19, 2025. This non-set-aside contract uses firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $16,233.74 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price, competitively awarded delivery order was placed without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Imbruvica 140 mg capsules (120-count units) with a ceiling value of $10,822.49. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by November 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $8,116.87 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Imbruvica 140 mg capsules (90-count units). This non-set-aside, competitively awarded delivery order is scheduled for completion by October 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $7,575.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDCJDelivery Order
The Defense Logistics Agency awarded a $7,575.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 70 mg capsules (28-count packaging) with a completion date of June 24, 2025. This non-set-aside, competitively awarded contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for federal agencies including the Defense Health Agency and U.S. Coast Guard. As a primary vendor within DLA's Medical Supply Chain, the company maintains extensive experience delivering a broad portfolio of pharmaceutical products, medical supplies, brand-name and generic medications, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Imbruvica, a prescription medication, exemplifies the company's role in supporting military and federal healthcare systems through flexible contracting mechanisms that enable rapid procurement of essential pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 6/2/25 |